These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
3. Managing the underestimated risk of statin-associated myopathy. Rallidis LS; Fountoulaki K; Anastasiou-Nana M Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193 [TBL] [Abstract][Full Text] [Related]
4. [Creatine kinase increase under simvastatin--therapeutic consequences?]. Rasche-Schürmann CC; Picksak G; Stichtenoth DO Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017 [TBL] [Abstract][Full Text] [Related]
5. [Muscle problems due to statins: underestimated]. Janssen SP; Smulders YM; Gerdes VE; Visseren FL Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278 [TBL] [Abstract][Full Text] [Related]
6. Outcomes in 45 patients with statin-associated myopathy. Hansen KE; Hildebrand JP; Ferguson EE; Stein JH Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427 [TBL] [Abstract][Full Text] [Related]
7. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Harper CR; Jacobson TA Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856 [TBL] [Abstract][Full Text] [Related]
8. Managing statin-induced muscle toxicity in a lipid clinic. Blaier O; Lishner M; Elis A J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023 [TBL] [Abstract][Full Text] [Related]
9. Clinical characterization and molecular mechanisms of statin myopathy. Toth PP; Harper CR; Jacobson TA Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):955-69. PubMed ID: 18666846 [TBL] [Abstract][Full Text] [Related]
10. Muscle symptoms associated with statins: a series of twenty patients. Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891 [TBL] [Abstract][Full Text] [Related]
16. Current overview of statin-induced myopathy. Rosenson RS Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590 [TBL] [Abstract][Full Text] [Related]
17. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization. Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281 [TBL] [Abstract][Full Text] [Related]
18. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge. Fung EC; Crook MA Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002 [TBL] [Abstract][Full Text] [Related]